Califf Hints At Labeling Changes For Opioids And Chronic Pain

 
• By Sarah Karlin-Smith
  
person in pain
The FDA Commissioner Highlighted a New CDC Report Citing ‘No Evidence’ Of Chronic Opioid Benefit When Discussing Potential Labeling Changes. • Source: Shutterstock

More from Approval Standards

More from Pathways & Standards